founded in 2017, has developed a proprietary machine learning-driven solution for the discovery of best-in-class and first-in-class epitope-selective immunomodulatory therapies for cancer and ...

T cell epitope-driven vaccine design employs bioinformatic algorithms to identify potential targets of vaccines against infectious diseases or cancer. Potential epitopes can be identified with ...

Using a curated dataset of over 650,000 unique human leukocyte antigen (HLA) ligands and cutting-edge AI architectures, MUNIS significantly outperformed existing epitope prediction models.

XtalPi, an AI drug discovery company and subsidiary of Ailux ... It has shown significant results in applications including ...

"Our computational modeling accurately predicts epitope binding ... This accelerates the pace of antibody discovery and development, ultimately leading to novel therapeutics with enhanced efficacy.